NEW YORK (Reuters Health) – In selected patients, colectomy can be performed laparoscopically via a single port. However, the advantages of this technique over multiport laparoscopic colectomy seem…
NEW YORK (Reuters Health) – Treatment with the angiotensin receptor blocker (ARB) candesartan is not associated with either carcinogenesis or cancer death compared with non-ARB standard antihypertensive treatment,…
NEW YORK (Reuters Health) – Bone loss in postmenopausal women taking adjuvant letrozole for early breast cancer can be prevented with administration of zoledronic acid, investigators report in…
NEW YORK (Reuters Health) – In the rituximab era, it’s not necessary to administer prophylaxis against central nervous system (CNS) disease in patients with diffuse large B-cell lymphoma…
NEW YORK (Reuters Health) – The number of monitoring visits for patients treated for localized primary melanoma can be reduced considerably, without having much effect on spotting any…
NEW YORK (Reuters Health) – Vandetanib shows encouraging action against advanced and metastatic medullary thyroid carcinoma, researchers report in an October 24th on-line paper in the Journal of…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – After organ transplantation, the overall risk of any new malignancy doubles, according to a new report from the U.S. National Cancer Institute. The…
NEW YORK (Reuters Health) – For women with advanced breast cancer, capecitabine provides similar overall survival with less toxicity compared with classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line…
NEW YORK (Reuters Health) – For the majority of women undergoing gynecologic surgery for benign conditions, intermittent pneumatic compression provides sufficient protection against venous thromboembolism (VTE). Women at…